Symrise AG undergoes a significant leadership transition as Dr. Heinz-Jürgen Bertram concludes his 15 years of successful tenure as CEO. Stepping into this role is Dr. Jean-Yves Parisot, an accomplished executive within the company, set to assume the position on March 31, 2024. Dr. Parisot, currently overseeing the Taste, Nutrition & Health segment, secures his leadership role with a contract extension until September 2028. This shift ensures a seamless and trustworthy handover by the end of March 2024.
Michael König, the chairman of the supervisory board, extends gratitude to Dr. Bertram for his transformative leadership, shaping Symrise into a global industry leader. Dr. Bertram, concluding his 21 years of service with 15 as CEO, retires with mutual consent.
Expressing confidence in Dr. Parisot, König highlights his international experience and successful collaboration with Dr. Bertram in steering Symrise through transformation. Dr. Parisot, acknowledging Symrise’s robust foundation, underscores a continued dedication to strategic growth for sustained success.
A member of the executive committee since 2016, Dr. Parisot will oversee the Taste, Nutrition & Health segment on an interim basis until a successor is identified. His global leadership roles at reputable companies position Symrise for ongoing success.
Advertisement
